CytomX Therapeutics, Inc. (CTMX): Operating Income
-$22.36M
Year ended 2025-12-31
-$87.15M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$22.36M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $25.00M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$6.48M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$101.33M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$116.04M | n/m | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | -$80.54M | n/m | 2023-03-27, From 2020-01-01 |
| 2019-12-31 | -$141.48M | n/c | 2023-03-27, From 2019-01-01 |
| 2018-12-31 | -$77.87M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$46.26M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$59.59M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$33.20M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$29.77M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$14.96M | n/a | 2016-03-07, From 2013-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$22.36M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$217.10M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | -$844.0K | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$247.06M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$12.12M | n/m |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$121.50M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$363.39M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$76.26M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$4.69M | n/m |
Compare CTMX, ABCL, ETON, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗